Broncus Medical Inc., a provider of precision intervention solutions for lung diseases with operations in Shanghai, Hangzhou (China), and San Jose, Seattle (United States), has received approval from the Zhejiang Medical Products Administration to market its BroncQCT lung image processing software in China.
Software Functionality
BroncQCT processes CT images through advanced algorithms, performing segmentation and analysis of lung segments. It achieves quantitative data visualization and three-dimensional reconstruction of lung structures, enabling multiple applications. The software can be used for efficient large-scale imaging screening in patient populations, identifying patients with specific lung characteristics.
Market Potential and Applications
The approval marks a significant milestone for Broncus Medical, allowing the company to introduce its innovative imaging solution to the Chinese market. BroncQCT’s capabilities position it as a valuable tool for healthcare providers in the diagnosis and management of lung diseases, offering improved efficiency and accuracy in identifying patients with specific lung conditions.-Fineline Info & Tech
Leave a Reply